Erasca to Present at Upcoming Investor Conferences in September
Erasca (Nasdaq: ERAS), a clinical-stage precision oncology company, has announced its participation in two major investor conferences in September 2024. The company will present at the 22nd Annual Morgan Stanley Global Healthcare Conference on September 5 and the 2024 Cantor Global Healthcare Conference on September 18, both in New York City.
At both events, Erasca's management will engage in fireside chats and one-on-one investor meetings. The Morgan Stanley conference presentation is scheduled for 12:20 - 12:55 pm ET, while the Cantor conference slot is 3:40 - 4:10 pm ET. Live audio webcasts of these events will be available on Erasca's website, with archived replays accessible for 30 days post-event.
Erasca (Nasdaq: ERAS), un'azienda di oncologia di precisione in fase clinica, ha annunciato la sua partecipazione a due importanti conferenze per investitori a settembre 2024. L'azienda presenterà alla 22ª Conferenza Globale sulla Sanità di Morgan Stanley il 5 settembre e alla Conferenza Globale sulla Sanità di Cantor 2024 il 18 settembre, entrambe a New York.
In entrambi gli eventi, il management di Erasca parteciperà a chiacchierate informali e incontri one-on-one con gli investitori. La presentazione della conferenza di Morgan Stanley è prevista per le 12:20 - 12:55 ora dell'Est, mentre la sessione della conferenza di Cantor si terrà dalle 15:40 alle 16:10 ora dell'Est. Webcast audio in diretta di questi eventi saranno disponibili sul sito web di Erasca, con replay archiviati accessibili per 30 giorni dopo l'evento.
Erasca (Nasdaq: ERAS), una empresa de oncología de precisión en etapa clínica, ha anunciado su participación en dos grandes conferencias para inversores en septiembre de 2024. La empresa presentará en la 22ª Conferencia Anual de Salud Global de Morgan Stanley el 5 de septiembre y en la Conferencia Global de Salud de Cantor 2024 el 18 de septiembre, ambas en la ciudad de Nueva York.
En ambos eventos, la dirección de Erasca participará en charlas informales y en reuniones individuales con inversores. La presentación en la conferencia de Morgan Stanley está programada para las 12:20 - 12:55 pm ET, mientras que el horario de la conferencia de Cantor es de 3:40 a 4:10 pm ET. Transmisiones en vivo por audio de estos eventos estarán disponibles en el sitio web de Erasca, con repeticiones archivadas accesibles durante 30 días después del evento.
에라스카 (Nasdaq: ERAS), 임상 단계의 정밀 온콜로지 회사가 2024년 9월 두 개의 주요 투자자 회의에 참여한다고 발표했습니다. 이 회사는 9월 5일에 제22회 모건스탠리 글로벌 헬스케어 컨퍼런스와 9월 18일에 2024 칸토 글로벌 헬스케어 컨퍼런스에서 발표합니다. 두 회의 모두 뉴욕 시에서 열립니다.
두 행사 모두에서 에라스카의 경영진은 비공식적인 대화와 일대일 투자자 미팅에 참여할 예정입니다. 모건스탠리 회의 발표는 동부 시간으로 오후 12:20 - 12:55로 예정되어 있으며, 칸토 회의는 오후 3:40 - 4:10로 예정되어 있습니다. 이 행사들의 실시간 오디오 웹캐스트는 에라스카의 웹사이트에서 제공되며, 이벤트 종료 후 30일 동안 아카이브된 재생이 가능합니다.
Erasca (Nasdaq: ERAS), une entreprise de cancérologie de précision au stade clinique, a annoncé sa participation à deux grandes conférences pour investisseurs en septembre 2024. L'entreprise présentera lors de la 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le 5 septembre et lors de la Conférence Mondiale sur la Santé de Cantor 2024 le 18 septembre, toutes deux à New York City.
Lors de ces deux événements, la direction d'Erasca participera à des discussions informelles et à des réunions en tête-à-tête avec des investisseurs. La présentation à la conférence Morgan Stanley est prévue de 12h20 à 12h55 HNE, tandis que le créneau de la conférence Cantor est de 15h40 à 16h10 HNE. Des diffusions audio en direct de ces événements seront disponibles sur le site web d'Erasca, avec des rediffusions accessibles pendant 30 jours après l'événement.
Erasca (Nasdaq: ERAS), ein Unternehmen der präzisen Onkologie in der klinischen Phase, hat seine Teilnahme an zwei großen Investorenkonferenzen im September 2024 angekündigt. Das Unternehmen wird am 5. September auf der 22. jährlichen Morgan Stanley Global Healthcare Conference und am 18. September auf der 2024 Cantor Global Healthcare Conference in New York City präsentieren.
Bei beiden Veranstaltungen wird das Management von Erasca an informellen Gesprächen und persönlichen Investorengesprächen teilnehmen. Die Präsentation auf der Morgan Stanley-Konferenz ist für 12:20 - 12:55 Uhr ET angesetzt, während der Slot der Cantor-Konferenz von 15:40 bis 16:10 Uhr ET angesetzt ist. Live-Audio-Webcasts dieser Veranstaltungen werden auf der Website von Erasca verfügbar sein, wobei archivierte Wiederholungen 30 Tage nach dem Event zugänglich sind.
- None.
- None.
SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in the following investor conferences in September 2024 and will also participate in one-on-one investor meetings.
22nd Annual Morgan Stanley Global Healthcare Conference
Location: New York Marriott Marquis, New York, NY
Format: Fireside Chat
Date and Time: Thursday, September 5, 12:20 – 12:55 pm Eastern Time
2024 Cantor Global Healthcare Conference
Location: InterContinental Barclay, New York, NY
Format: Fireside Chat
Date and Time: Wednesday, September 18, 3:40 – 4:10 pm Eastern Time
A live audio webcast of the events will be available online at Erasca.com/events. An archived replay of the events will be available for 30 days following the webcast at Erasca.com/events.
About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. We have assembled one of the deepest RAS/MAPK pathway-focused pipeline in the industry. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.
Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com
Source: Erasca, Inc.
FAQ
What investor conferences will Erasca (ERAS) attend in September 2024?
When and where is Erasca's (ERAS) presentation at the Morgan Stanley conference?
What is the format of Erasca's (ERAS) presentations at the September 2024 conferences?
How can investors access Erasca's (ERAS) conference presentations in September 2024?
